| Trial ID: | L3552 |
| Source ID: | NCT02920801
|
| Associated Drug: |
Saxagliptin
|
| Title: |
Study About Effect of Saxagliptin on Circulating Endothelial Progenitor Cells and Endothelial Function in Newly Diagnosed Type 2 Diabetic Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: saxagliptin|DRUG: Metformin
|
| Outcome Measures: |
Primary: endothelial progenitor cell, 12weeks|flow-mediated dilation, 12weeks | Secondary: HbA1c, 12weeks|fasting blood glucose, 12weeks|2 hour postprandial blood glucose, 12weeks|liver function test, 12weeks|renal function test, 12weeks
|
| Sponsor/Collaborators: |
Sponsor: Shanghai Zhongshan Hospital | Collaborators: Chinese Medical Association
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
31
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2014-12
|
| Completion Date: |
2015-07
|
| Results First Posted: |
|
| Last Update Posted: |
2016-10-03
|
| Locations: |
Fang Li, Shanghai, Shanghai, 200032, China
|
| URL: |
https://clinicaltrials.gov/show/NCT02920801
|
